Identification of expressed genes characterizing long-term survival in malignant glioma patients (Q40284703)

19 September 2017

Identification of expressed genes characterizing long-term survival in malignant glioma patients (English)

1 reference

19 September 2017

1

1 reference

19 September 2017

Arao T

2

1 reference

19 September 2017

Yajima N

3

1 reference

19 September 2017

Tsuchiya N

4

1 reference

19 September 2017

Homma J

5

1 reference

19 September 2017

Tanaka R

6

1 reference

19 September 2017

Sano M

7

1 reference

19 September 2017

Oide A

8

1 reference

19 September 2017

Sekijima M

9

1 reference

19 September 2017

Nishio K

10

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

25

1 reference

19 September 2017

44

1 reference

19 September 2017

5994-6002

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209585

19 September 2017

0 references

cites work

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profiling of gliomas strongly predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

DNA-microarray analysis of brain cancer: molecular classification for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Identification of molecular subtypes of glioblastoma by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

A novel serum protein that is selectively produced by cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profiling and genetic markers in glioblastoma survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profiling identifies molecular subtypes of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Discoidin domain receptor 1 is activated independently of beta(1) integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Growth factor receptor tyrosine kinases: cell adhesion kinase family suggests a novel signaling mechanism in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Discoidin domain receptor 1: a new class of receptor regulating leukocyte-collagen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

Discoidin domain receptors: structural relations and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209585

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1209585

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference